Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Firms Marketing In Japan Should Plan For License Renewals Under New Law

This article was originally published in The Gray Sheet

Executive Summary

Device manufacturers that obtained a Japanese marketing license ("kyoka") in Japan before the revised Pharmaceutical Affairs Law (PAL) went into effect last April should allow time to come into compliance before the license expires, according to Steve McRoberts, global principal engineer at Underwriters Laboratories

You may also be interested in...



Japanese quality system measures

Device firms selling in Japan should be aware that transitional quality system measures under Japanese Good Manufacturing Practice regulations will come into effect in April, according to Amanda Pack, senior project engineer and lead auditor for Underwriters Laboratories. Manufacturers pursuing certification of Class I and some Class II devices by a third party in Japan will have to adhere to the new manufacturing standards to receive a five-year certificate for their devices, but those firms that already have certifications will only have to adhere to the new standards when they apply for recertification, Pack said. Speaking during a Feb. 15 Regulatory Affairs Professionals Society webcast update on Japan regulatory practices, she noted that the transitional measures include review protocol, risk management, design and development protocol and others. Enacted under the Pharmaceutical Affairs Law in April 2005, the JGMP is similar to ISO 134859, the international quality systems standard (1"The Gray Sheet" Jan. 16, 2006, p. 8)...

Japanese quality system measures

Device firms selling in Japan should be aware that transitional quality system measures under Japanese Good Manufacturing Practice regulations will come into effect in April, according to Amanda Pack, senior project engineer and lead auditor for Underwriters Laboratories. Manufacturers pursuing certification of Class I and some Class II devices by a third party in Japan will have to adhere to the new manufacturing standards to receive a five-year certificate for their devices, but those firms that already have certifications will only have to adhere to the new standards when they apply for recertification, Pack said. Speaking during a Feb. 15 Regulatory Affairs Professionals Society webcast update on Japan regulatory practices, she noted that the transitional measures include review protocol, risk management, design and development protocol and others. Enacted under the Pharmaceutical Affairs Law in April 2005, the JGMP is similar to ISO 134859, the international quality systems standard (1"The Gray Sheet" Jan. 16, 2006, p. 8)...

Japanese Quality System Measures

Device firms selling in Japan should be aware that transitional quality system measures under Japanese Good Manufacturing Practice regulations will come into effect in April, according to Amanda Pack, senior project engineer and lead auditor for Underwriters Laboratories

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel